Advertisement

Correction to: Human skin-derived ABCB5+ stem cell injection improves liver disease parameters in Mdr2KO mice

  • Vanessa Hartwig
  • Bedair Dewidar
  • Tao Lin
  • Anne Dropmann
  • Christoph Ganss
  • Mark Andreas Kluth
  • Nils Tappenbeck
  • Lysann Tietze
  • Bruno Christ
  • Markus Hermann Frank
  • Roger Vogelmann
  • Matthias Philip Alexander Ebert
  • Steven DooleyEmail author
Correction
  • 153 Downloads

Correction to: Archives of Toxicology (2019) 93:2645–2660  https://doi.org/10.1007/s00204-019-02533-3

We wish to submit a corrigendum to the above-mentioned article. Thank you very much for consideration and publication.

Conflict of interest Vanessa Hartwig, Steven Dooley, Lysann Tietze and Bruno Christ participate in corporate-sponsored research collaborations with RHEACELL GmbH and Co. KG (Heidelberg, Germany). Christoph Ganss is CEO and Mark A. Kluth is CSO of RHEACELL and TICEBA GmbH (Heidelberg, Germany). Nils Tappenbeck is project manager at RHEACELL. Markus H. Frank is an inventor of ABCB5-related United States and international patents assigned to Boston Children’s Hospital and/or Brigham and Women’s Hospital (Boston, Massachusetts) and licensed to TICEBA and RHEACELL and serves as a scientific advisor to TICEBA and RHEACELL. The remaining authors have no conflicting interests. Data and data presentation are uninfluenced by TICEBA and RHEACELL.

Then in the abstract of the manuscript, “resulted from ABCB5+ cell transformation” should be “resulted from ABCB5+ cell transplantation”.

Additionally, amongst the list of authors, “Markus Frank” should be “Markus Hermann Frank”.

Notes

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Vanessa Hartwig
    • 1
  • Bedair Dewidar
    • 1
    • 2
  • Tao Lin
    • 1
  • Anne Dropmann
    • 1
  • Christoph Ganss
    • 3
    • 4
  • Mark Andreas Kluth
    • 3
    • 4
  • Nils Tappenbeck
    • 3
  • Lysann Tietze
    • 5
  • Bruno Christ
    • 5
  • Markus Hermann Frank
    • 6
  • Roger Vogelmann
    • 1
  • Matthias Philip Alexander Ebert
    • 1
  • Steven Dooley
    • 1
    Email author
  1. 1.Section Molecular Hepatology, Department of Medicine II, Medical Faculty MannheimHeidelberg UniversityMannheimGermany
  2. 2.Department of Pharmacology and Toxicology, Faculty of PharmacyTanta UniversityTantaEgypt
  3. 3.RHEACELL GmbH and Co. KGHeidelbergGermany
  4. 4.TICEBA GmbHHeidelbergGermany
  5. 5.Applied Molecular Hepatology, Department of Visceral Transplantation, Thoracic und Vascular SurgeryLeipzig UniversityLeipzigGermany
  6. 6.Department of Pediatrics and DermatologyHarvard Medical SchoolBostonUSA

Personalised recommendations